IP Library Granted Patent US 8,236,542
Granted Patent B2
US 8,236,542 · App. 12/477,887 · Granted Aug 7, 2012

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,542
App. No.
12/477,887
Granted
Aug 7, 2012
Kind
B2
Abstract

The present disclosure relates to cellulase variants. In particular the present disclosure relates to cellulase variants having reduced binding to non-cellulosic materials. Also described are nucleic acids encoding the cellulase, compositions comprising said cellulase, methods of identifying cellulose variants and methods of using the compositions.

Claims (16)

1. An isolated cellulase variant, comprising a sequence that is at least 95% identical to the amino acid sequence of a reference cellobiohydrolase II (CBH2) set forth as SEQ ID NO:3, wherein said variant is a mature form having cellulase activity and comprising a substitution at position 63, wherein the position is numbered by correspondence with the amino acid sequence of SEQ ID NO:3, and wherein the substitution causes the cellulase variant to have a more negative net charge in comparison to the reference CBH2.

2. The isolated cellulase variant of claim 1 , wherein the substitution at position 63 comprises removal of one or more positive charges.

3. The isolated cellulase variant of claim 2 , wherein the removal of one or more positive charges comprises a replacement of an arginine with a neutral amino acid.

4. The isolated cellulase variant of claim 1 , wherein the substitution at position 63 comprises addition of one or more negative charges.

5. The isolated cellulase variant of claim 1 , wherein the substitution at position 63 comprises removal of one or more positive charges and addition of one or more negative charges.

6. The isolated cellulase variant of claim 5 , wherein the removal of one or more positive charges and addition of one or more negative charges comprises a replacement of an arginine with a negatively charged amino acid.

7. The isolated cellulase variant of claim 1 , wherein the variant comprises a further substitution at one or more further positions selected from the group consisting of 146, 151, 189, 208, 211, 244, 277 and 405, wherein the further positions are numbered by correspondence with the amino acid sequence of the reference cellobiohydrolase II (CBH2) set forth as SEQ ID NO:3.

8. The isolated cellulase variant of claim 7 , wherein the further substitution at one or more further positions comprises a replacement of aspartic acid or glutamic acid with a neutral amino acid.

9. The isolated cellulase variant of claim 7 , wherein the further substitution at one or more further positions comprises one or more of the group consisting of D151N, D189N, D211N, D277N, D405N, E146Q, E208Q, and E244Q, wherein the positions are numbered by correspondence with the amino acid sequence of the reference cellobiohydrolase II (CBH2) set forth as SEQ ID NO:3.

10. The isolated cellulase variant of claim 1 , wherein the cellulase variant is derived from a parent cellulase selected from the group consisting of Hypocrea jecorina CBH2, Hypocrea koningii CBH2, Humicola insolens CBH2, Acremonium cellulolyticus CBH2, Agaricus bisporus CBH2, Fusarium osysporum EG, Phanerochaete chrysosporium CBH2, Talaromyces emersonii CBH2, Thermobifida fusca 6B/E3 CBH2, Thermobifida fusca 6A/E2 EG, and Cellulomonas fimi CenA EG.

11. The isolated cellulase variant of claim 1 , wherein the cellulase variant is derived from a parent cellulase whose amino acid sequence is at least 97% identical to a member of the group consisting of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, and SEQ ID NO:13.

12. The isolated cellulase variant of claim 1 , wherein the more negative net charge is a −1 or −2 in comparison to the reference CBH2.

13. A method of converting biomass to sugars comprising contacting said biomass with the cellulase variant of claim 1 .

14. A method of producing a fuel comprising:

contacting a biomass composition with an enzymatic composition comprising the cellulase variant of claim 1 to yield a sugar solution; and

culturing the sugar solution with a fermentative microorganism under conditions sufficient to produce a fuel.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: DANISCO US INC.
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 046572/0187 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME: DANISCO US INC., GENENCOR DIVISION PREVIOUSLY RECORDED ON REEL 026697 FRAME 0627. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 11, 2011
From: DANISCO US INC., GENENCOR DIVISION
To: DANISCO US INC.
Reel/Frame 027220/0296 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 12/477,877 PREVIOUSLY RECORDED ON REEL 022991 FRAME 0290. ASSIGNOR(S) HEREBY CONFIRMS THE THE APPLICATION NO. SHOULD HAVE BEEN 12/477,887. Recorded Aug 3, 2011
From: CASCAO-PEREIRA, LUIS; KAPER, THIJS; KELEMEN, BRADLEY R.; LIU, AMY D.
To: DANISCO US INC., GENENCOR DIVISION
Reel/Frame 026697/0627 →
CONFIRMATORY LICENSE Recorded Dec 13, 2010
From: DANISCO US INC.
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 025578/0337 →
Continuity (2)
Provisional Application 61059506 · Jun 6, 2008
Related Publication 20100041104A1 · Feb 18, 2010